Top Ten Common Prejudices About Polyethylene Naphthalate Market.

Image
In 2014, the global polyethylene naphthalate market was worth USD 827.0 million, and it is expected to grow at a CAGR of 7.5 percent over the next five years. Because of its improved thermal and barrier properties, such as oxidation resistance, polyethylene naphthalate (PEN) is primarily used in packaging applications. Over the forecast period, rising demand for high-strength photographic films is likely to drive market expansion. polyethylene naphthalate market Because of their higher stiffness modulus, PEN films are a major component of food packaging applications, providing increased barrier properties and enhancing the material's strength. These films are also used to make pressure sensitive tapes and thermal sheets. They are also involved in the protection of solar cells. Forward integration of raw material providers in PEN manufacturing is a feature of the polyethylene naphthalate market. These businesses actively consume raw materials in order to create their products. Con...

5 Awesome Things You Can Learn From Bacteriophage Therapy Market.



Increased prevalence of antibiotic-resistant illnesses, increased approvals of innovative products, and adoption of inorganic development tactics by major key companies are all prominent trends in the worldwide bacteriophage therapy market. These key trends are expected to help the market grow.

According to a study published in 2015 by the European Antimicrobial Resistance Surveillance Network (EARS-Net), antimicrobial resistant diseases kill roughly 33,000 individuals in Europe each year. According to the National Center for Global Health and Medicine, roughly 8,000 people died in Japan in 2017 as a result of medication resistance.

Furthermore, the market is predicted to develop due to increased approval and introduction of novel products over the forecast period. For example, Adaptive Phage Therapeutics gained orphan drug designation from the US Food and Drug Administration (FDA) in October 2020 for its PhageBank-based treatment of prosthetic joint infections (PJI).

In addition, prominent companies in the global bacteriophage therapy market are focusing on inorganic growth strategies such as acquisitions and collaborations to expand their market position in the worldwide market. For example, in January 2021, Eligo Bioscience SA signed a research agreement with GlaxoSmithKline (a pharmaceutical company) to advance Eligobiotics research and development for the treatment or prevention of acne vulgaris using a CRISPR-based therapeutic, which is a DNA genome known as clustered regularly interspaced short palindromic repeats (CRISPR-Cas3), for strain-specific sensitivity.

Due to the increased frequency of urinary tract infections and the development of novel medicines such as bacteriophage therapy for the treatment and management of urinary tract infections, the urinary tract infections sector will account for the biggest market share in 2020. According to a December 2019 research published in the National Center for Biotechnology Information, the prevalence of urinary tract infection (UTI) in women over 65 years of age is roughly 20%, compared to about 11% in the general population.

According to the survey, 50 percent to 60 percent of adult women are anticipated to experience at least one UTI during their lifetime, with roughly 10% of postmenopausal women reporting having experienced a UTI in the past.

Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Enbiotix, Inc., Intodeworld,


Comments

Popular posts from this blog

Top Ten Common Prejudices About Polyethylene Naphthalate Market.

The Ultimate Revelation Of Coal Fired Power Generation Market.

5 Various Ways To Do Obesity Management Drugs Market.